Postdoctoral Research Associate
01392 72 3898
Medical School Building F.08C
Medical School Building, St Luke's Campus, Magdalen Road, Exeter, EX1 2LU, UK
During her MSc degree in Biochemistry in the University of Bristol, Ling took a special interest in alternative splicing. From there Ling applied for a PhD position in Bristol with Dr Sebastian Oltean (now working at University of Exeter) to study modulation of alternative splicing regulators during EMT in cancer progression. While finishing her PhD, Ling had developed an interest in detection of EGFR mutations in the plasma and urine of NSCLC patients and continued to do a Post-doc with Dr Sebastian Oltean in Exeter since August 2018. Ling have a postdoctoral research associate position at the University of Exeter to working with Dr Sebatian Oltean.
Ling is working on grants/funding obtained by Dr Sebastian Oltean from Boehringer Ingelheim.
- PhD in Physiology, Pharmacology and Neuroscience (University of Bristol, 2014-now)
- MSc in Biochemistry (University of Bristol, 2012-2013)
- BSc in Bioscience (Southwest University, China, 2005-2009)
I am interested in alternative splicing in cancer, specifically, prostate cancer. Much of our research has been focused on alternative splicing regulators; however, our goals are to determine small molecules that are modulate splicing in prostate cancer, and to find out the mechanisms of these chemicals worked as a novel therapeutic way.
- Detection of genomic mutations in blood and urine free circulating tumour DNA in inoperable and metastatic lung adenocarcinoma harboring an EGFR mutation on tissue.
- Alternative splicing control in epithelial-mesenchymal transitions / ESRP splice factors in prostate cancer
- Investigation of new treatments in mouse models of diabetes
- Boehringer Ingelheim